These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 32379948

  • 21. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S, Pannecouque C, Daelemans D, Ma XD, Liu Y, Chen FE, De Clercq E.
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate.
    Yang G, Wang J, Cheng Y, Dutschman GE, Tanaka H, Baba M, Cheng YC.
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2035-42. PubMed ID: 18391035
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Design and synthesis of novel distamycin-modified nucleoside analogues as HIV-1 reverse transcriptase inhibitors.
    Li C, Ma C, Zhang J, Qian N, Ding J, Qiao R, Zhao Y.
    Antiviral Res; 2014 Feb; 102():54-60. PubMed ID: 24342709
    [Abstract] [Full Text] [Related]

  • 28. Carbocyclic dinucleoside polyphosphonates: interaction with HIV reverse transcriptase and antiviral activity.
    Khandazhinskaya AL, Shirokova EA, Skoblov YS, Victorova LS, Goryunova LY, Beabealashvilli RS, Pronyaeva TR, Fedyuk NV, Zolin VV, Pokrovsky AG, Kukhanova MK.
    J Med Chem; 2002 Mar 14; 45(6):1284-91. PubMed ID: 11881997
    [Abstract] [Full Text] [Related]

  • 29. Nucleoside diphosphate and triphosphate prodrugs - An unsolvable task?
    Meier C.
    Antivir Chem Chemother; 2017 Dec 14; 25(3):69-82. PubMed ID: 29096525
    [Abstract] [Full Text] [Related]

  • 30. Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents.
    Keane SJ, Ford A, Mullins ND, Maguire NM, Legigan T, Balzarini J, Maguire AR.
    J Org Chem; 2015 Mar 06; 80(5):2479-93. PubMed ID: 25532055
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
    Agarwal HK, Chhikara BS, Doncel GF, Parang K.
    Bioorg Med Chem Lett; 2017 May 01; 27(9):1934-1937. PubMed ID: 28351588
    [Abstract] [Full Text] [Related]

  • 32. 2',3'-dideoxynucleoside 5'-beta, gamma-(difluoromethylene) triphosphates with alpha-P-thio or alpha-P-seleno modifications: synthesis and their inhibition of HIV-1 reverse transcriptase.
    Boyle NA, Fagan P, Brooks JL, Prhavc M, Lambert J, Cook PD.
    Nucleosides Nucleotides Nucleic Acids; 2005 May 01; 24(10-12):1651-64. PubMed ID: 16438041
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X, Zhan P, Liu X, Cheng Z, Meng C, Shao S, Pannecouque C, De Clercq E, Liu X.
    Bioorg Med Chem; 2012 Jun 15; 20(12):3856-64. PubMed ID: 22591854
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates.
    Dash C, Ahmadibeni Y, Hanley MJ, Pandhare J, Gotte M, Le Grice SF, Parang K.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3519-22. PubMed ID: 21605974
    [Abstract] [Full Text] [Related]

  • 36. Antiviral Activity of Lipophilic Nucleoside Tetraphosphate Compounds.
    Jia X, Schols D, Meier C.
    J Med Chem; 2024 Feb 22; 67(4):2864-2883. PubMed ID: 38345794
    [Abstract] [Full Text] [Related]

  • 37. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
    Meng G, Liu Y, Zheng A, Chen F, Chen W, De Clercq E, Pannecouque C, Balzarini J.
    Eur J Med Chem; 2014 Jul 23; 82():600-11. PubMed ID: 24952305
    [Abstract] [Full Text] [Related]

  • 38. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS.
    Biochim Biophys Acta; 2002 Jul 18; 1587(2-3):296-9. PubMed ID: 12084471
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
    Shi J, McAtee JJ, Schlueter Wirtz S, Tharnish P, Juodawlkis A, Liotta DC, Schinazi RF.
    J Med Chem; 1999 Mar 11; 42(5):859-67. PubMed ID: 10072683
    [Abstract] [Full Text] [Related]

  • 40. Strategies in the design of prodrugs of anti-HIV agents.
    Calogeropoulou T, Detsi A, Lekkas E, Koufaki M.
    Curr Top Med Chem; 2003 Mar 11; 3(13):1467-95. PubMed ID: 14529522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.